Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

Reducing the harms of xylazine: clinical approaches, research deficits, and public health context

Abstract Objectives Xylazine has emerged as a consistent part of the unregulated drug supply in recent months. We discuss major domains of xylazine’s harm, current knowledge deficits, clinical and harm reduction strategies for minimizing harm, and xylazine’s public health and policy context. As an i...

Full description

Bibliographic Details
Main Authors: Claire M. Zagorski, Rebecca A. Hosey, Christopher Moraff, Aaron Ferguson, Mary Figgatt, Shoshana Aronowitz, Natalie E. Stahl, Lucas G. Hill, Zoe McElligott, Nabarun Dasgupta
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Harm Reduction Journal
Subjects:
Xylazine
Harm reduction
Wounds
Drug injection
Online Access:https://doi.org/10.1186/s12954-023-00879-7

Internet

https://doi.org/10.1186/s12954-023-00879-7

Similar Items